Industry Focus

CVS's plan to boost prescription revenue by abandoning Tobacco might be panning out, and Regeneron's pricey new drug could become a multibillion blockbuster.

Direct download: 150805_IF_Healthcare.mp3
Category:Podcast -- posted at: 4:26pm EST

1